Natriuretic peptide system in human heart failure

Circulation

Volumn 88, Issue 3, 1993, Pages 1004-1009

  Wei, Chi Ming ^a   Heublein, Denise M ^a   Perrella, Mark A ^a   Lerman, Amir ^a   Rodeheffer, Richard J ^a   McGregor, Christopher G A ^a   Edwards, William D ^a   Schaff, Hartzell V ^a   Burnett Jr , John C ^a  

^a MAYO CLINIC   (United States)

Author keywords

Heart failure; Left ventricle; Natriuretic peptides

Indexed keywords

ATRIAL NATRIURETIC FACTOR; BRAIN NATRIURETIC PEPTIDE; NATRIURETIC FACTOR;

ADULT; ARTICLE; CLINICAL ARTICLE; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; FEMALE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HORMONE BLOOD LEVEL; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; PRIORITY JOURNAL; RADIOIMMUNOASSAY; TISSUE LEVEL;

ATRIAL NATRIURETIC FACTOR; FEMALE; HEART ATRIUM; HEART FAILURE, CONGESTIVE; HEART VENTRICLE; HUMAN; MALE; MIDDLE AGE; MYOCARDIUM; NATRIURETIC PEPTIDE, BRAIN; NATRIURETIC PEPTIDE, C-TYPE; NERVE TISSUE PROTEINS; RADIOIMMUNOASSAY; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0027162016     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.88.3.1004     Document Type: Article

References (36)

1. Burnett JC Jr, Granger JP, Opgenorth TJ. Effects of synthetic atrial natriuretic factor on renal function and renin release. Am J Physiol. 1984;247:F863-F866.
2. De Bold AJ, Borenstein HB, Veress AT, Sonnenberg H. A rapid and potent natriuretic response to intravenous injection of atrial myocardial extracts in rats. Life Sci. 1981;28:89-94.
3. Wei CM, Heublein DM, Burnett JC Jr. Pathophysiologic concentrations of human brain natriuretic peptide have functionally important biological actions in vivo. J Am Soc Nephrol. 1991;2:422. Abstract.
4. Komatsu Y, Nakao K, Suga S, Ogawa Y, Mukoyama M, Arai H, Shirakami G, Hosoda K, Nakagawa O, Hama N. C-type natriuretic peptide in rats and humans. Endocrinology. 1991;129:1104-1106.
5. Stingo AJ, Clavell AL, Aarhus LL, Burnett JC Jr. Cardiovascular and renal actions of C-type natriuretic peptide. Am J Physiol. 1992;262:H308-H312.
6. Takahashi T, Allen PD, Izumo S. Expression of A-, B-, and C-type natriuretic peptide genes in failing and developing human ventricles. Circ Res. 1992;71:9-17.
7. Ueda S, Minamino N, Aboraya M, Kangawa K, Matsukaua S, Matsuo H. Distribution and characterization of immunoreactive porcine C-type natriuretic peptide. Biochem Biophys Res Commun. 1991;175:759-767.
8. Heublein DM, Clavell AL, Stingo AJ, Lerman A, Wold L, Burnett JC Jr. C-type natriuretic peptide immunoreactivity in human breast vascular endothelial cells. Peptides. 1992;13:1017-1019.
9. Stingo AJ, Clavell AJ, Heublein DM, Wei CM, Pittelkow MR, Burnett JC Jr. Presence of C-type natriuretic peptide in cultured human endothelial cells and plasma. Am J Physiol. 1992;263: H1318-H1321.
10. Suga S, Nakao K, Itoh H, Komatsu Y, Ogawa Y, Hama N, Imura H. Endothelial production of C-type natriuretic peptide and its marked augmentation by transforming growth factor-β: possible existence of "vascular natriuretic peptide system." J Clin Invest. 1992;90:1145-1149.
11. Koller KJ, Lowe DG, Bennett GL, Minamino N, Kangawa K, Matsuo H, Goeddel DV. Selective activation of the B-natriuretic peptide receptor by C-type natriuretic peptide (CNP). Science. 1991;252:120-123.
12. Nunez DJR, Dickson CM, Brown KJ. Natriuretic peptide receptor mRNAs in the rat and human heart. J Clin invest. 1992;90: 1966-1971.
13. Burnett JC Jr, Kao PC, Hu DC, Heser D, Heublein D, Granger J, Opgenorth T, Reeder G. Atrial natriuretic peptide elevation in congestive heart failure in the human. Science. 1986;231:1145-1147.
14. Cody RJ, Atlas SA, Laragh JH, Kubo SH, Covit AB, Ryman S, Shaknovich A, Pondolfino K, Clark M, Camargo MJF, Scarborough RM. Atrial natriuretic factor in normal subjects and heart failure patients. J Clin Invest. 1986;78:1362-1374.
15. Edwards BS, Ackermann DM, Lee ME, Reeder GS, Wold LE, Burnett JC Jr. Identification of atrial natriuretic factor within ventricular tissue in hamsters and humans with congestive heart failure. J Clin Invest. 1988;81:82-86.
16. Saito Y, Nakao K, Arai H, et al. Augmented expression of atrial natriuretic polypeptide gene in ventricle of human failing heart. J Clin Invest. 1989;83:298-305.
17. Richards AM, Cleland JGF, Tonolo G, McIntyre GD, Leckie BJ, Dargie HJ, Ball SG, Robertson JIS. Plasma α natriuretic peptide in cardiac impairment. Br Med J. 1986;293:409-412.
18. Mukoyama M, Nakao K, Hosoda K, et al. Brain natriuretic peptide as a novel cardiac hormone in humans: evidence for an exquisite dual natriuretic peptide system, atrial natriuretic peptide and brain natriuretic peptide. J Clin Invest. 1991;87:1402-1412.
19. Awazu M, Imada T, Kon V, Inagami T, Ichikawa I. Role of endogenous atrial natriuretic peptide in congestive heart failure. Am J Physiol. 1989;257:R641-R646.
20. Drexler H, Hanze J, Finckh M, Lu W, Just H, Lange RE. Atrial natriuretic peptide in a rat model of cardiac failure: atrial and ventricular mRNA, atrial content, plasma levels, and effect of volume loading. Circulation. 1989;79:620-633.
21. Lee ME, Miller WL, Edwards BS, Burnett JC Jr. Role of endogenous atrial natriuretic factor in acute congestive heart failure. J Clin Invest. 1989;84:1962-1966.
22. Clavell AL, Stingo AJ, Wei CM, Heublein DM, Burnett JC Jr. C-type natriuretic peptide: a selective cardiovascular peptide. Am J Physiol. 1993;264:R290-R295.
23. Perrella MA, Schwab TR, O'Murchu B, Redfield MM, Wei CM, Edwards BS, Burnett JC Jr. Cardiac atrial natriuretic factor during evolution of congestive heart failure. Am J Physiol. 1992;262: H1248-H1255.
24. Gutkowska J, Horky K, Lachance C, Racz R, Garcia G, Thibault G, Kuchel O, Genest J, Cantin M. Atrial natriuretic factor in spontaneously hypertensive rats. Hypertension. 1986;8(suppl I): I-137-I-140.
25. Chapeau C, Gutkowska J, Schiller PW, Milne RW, Thibault G, Garcia R, Genest J, Cantin M. Localization of immunoreactive synthetic atrial natriuretic factor (ANF) in the heart of various animal species. J Histochem Cytochem. 1985;33:541-550.
26. Edwards BS, Ackermann DM, Schwab TR, Heublein DM, Edwards WD, Wold LE, Burnett JC Jr. The relationship between atrial granularity and circulating atrial natriuretic peptide in hamsters with congestive heart failure. Mayo Clin Proc. 1986;61: 517-521.
27. Francis GS, Benedict C, Johnstone DE, Benedict C, Johnstone EJ, Kirlin PC, Nicklas J, Liang CS, Kubo SH, Rudin-Toretsky E, Yusuf S. Comparison of neuroendocrine activation in patients with left ventricular dysfunction with and without congestive heart failure: a substudy of the Studies of Left Ventricular Dysfunction (SOLVD). Circulation. 1990;82:1724-1729.
28. Lerman A, Gibbons RJ, Rodeheffer RJ, Bailey KR, McKinley LJ, Heublein DM, Burnett JC Jr. Circulating N-terminal atrial natriuretic peptide as a marker for symptomless left-ventricular dysfunction. Lancet 1993;341:1105-1109.
29. Brandt RR, Wright S, Aarhus LL, Lewicki JA, Burnett JC Jr. Modulation of metabolic clearance rate of atrial natriuretic factor (ANF) by clearance receptor blockade in experimental congestive heart failure (CHF) in dogs. Circulation. 1992;86(suppl I):I-51. Abstract.
30. Suzuki E, Hirata Y, Kohmoto O, Sugimoto T, Hayakawa H, Matsuoka H, Sugimoto T, Kojima M, Kangawa K, Minamino N, Matsuo H. Cellular mechanisms for synthesis and secretion of atrial natriuretic peptide and brain natriuretic peptide in cultured rat atrial cells. Circ Res. 1992;71:1039-1048.
31. Kubo SH, Rector TS, Bank AJ, Williams RE, Heifetz SM. Endothelium-dependent vasodilation is attenuated in patients with heart failure. Circulation. 1991;84:1589-1596.
32. Margulies KB, Heublein DM, Perrella MA, Burnett JC Jr. ANF-mediated renal cGMP generation in congestive heart failure. Am J Physiol. 1991;260:F562-F568.
33. Yoshimura M, Yasue H, Morita E, Sakaino N, Jougasaki M, Kurose M, Mukoyama M, Saito Y, Nakao K, Imura H. Hemodynamic, renal, and hormonal responses to brain natriuretic peptide infusion in patients with congestive heart failure. Circulation. 1991;84:1581-1588.
34. Clavall AL, Stingo AJ, Aarhus LL, Burnett JC Jr. Biological actions of brain natriuretic peptide in inferior vena caval constriction. Am. J. Physiol. 1993, in press.
35. Hoffman A, Grossman E, Keiser HR. Increased plasma levels and blunted effects of brain natriuretic peptide in rats with congestive heart failure. Am J Hypertens. 1991;4:597-601.
36. Wei CM, Aarhus LL, Miller VM, Burnett JC Jr. The action of C-type natriuretic peptide in isolated canine arteries and veins. Am J Physiol. 1993;264:H71-H73.